Register entry
- Registered sites
- 0
- Active NDC listings
- 39
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
3939 active NDC listings: 39 human prescription drug. By marketing category: DRUG FOR FURTHER PROCESSING 39.
| Dosage form | NDCs |
|---|---|
| tablet | 14 |
| tablet, film coated | 9 |
| injection, solution | 5 |
| capsule | 4 |
| tablet, for suspension | 4 |
| injection | 1 |
| injection, powder, for solution | 1 |
| injection, solution, concentrate | 1 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| novartis pharma stein ag | 39 |
Catalogue
Marketed products
39| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Fingolimod hcl | capsule | 17088-0219DRUG FOR FURTHER PROCESSING |
| - | alpelisib | tablet | 17088-0170DRUG FOR FURTHER PROCESSING |
| - | alpelisib | tablet | 17088-0198DRUG FOR FURTHER PROCESSING |
| - | alpelisib | tablet | 17088-0205DRUG FOR FURTHER PROCESSING |
| - | alpelisib | tablet | 17088-0254DRUG FOR FURTHER PROCESSING |
| - | alpelisib | tablet | 17088-0322DRUG FOR FURTHER PROCESSING |
| - | alpelisib | tablet | 17088-0346DRUG FOR FURTHER PROCESSING |
| - | asciminib | tablet, film coated | 17088-0156DRUG FOR FURTHER PROCESSING |
| - | asciminib | tablet, film coated | 17088-0163DRUG FOR FURTHER PROCESSING |
| - | asciminib | tablet, film coated | 17088-0330DRUG FOR FURTHER PROCESSING |
| - | basiliximab | injection, powder, for solution | 17088-0370DRUG FOR FURTHER PROCESSING |
| - | canakinumab | injection, solution | 17088-0354DRUG FOR FURTHER PROCESSING |
| - | cyclosporine | injection | 17088-0362DRUG FOR FURTHER PROCESSING |
| - | dabrafenib | tablet, for suspension | 17088-0212DRUG FOR FURTHER PROCESSING |
| - | everolimus | tablet, for suspension | 17088-0107DRUG FOR FURTHER PROCESSING |
| - | everolimus | tablet, for suspension | 17088-0114DRUG FOR FURTHER PROCESSING |
| - | everolimus | tablet | 17088-0135DRUG FOR FURTHER PROCESSING |
| - | everolimus | tablet | 17088-0142DRUG FOR FURTHER PROCESSING |
| - | everolimus | tablet | 17088-0149DRUG FOR FURTHER PROCESSING |
| - | everolimus | tablet, for suspension | 17088-0247DRUG FOR FURTHER PROCESSING |
| - | everolimus | tablet | 17088-0261DRUG FOR FURTHER PROCESSING |
| - | everolimus | tablet | 17088-0290DRUG FOR FURTHER PROCESSING |
| - | everolimus | tablet | 17088-0298DRUG FOR FURTHER PROCESSING |
| - | everolimus | tablet | 17088-0306DRUG FOR FURTHER PROCESSING |
| - | everolimus | tablet | 17088-0314DRUG FOR FURTHER PROCESSING |
| - | letrozole | tablet, film coated | 17088-0100DRUG FOR FURTHER PROCESSING |
| - | nilotinib | capsule | 17088-0226DRUG FOR FURTHER PROCESSING |
| - | nilotinib | capsule | 17088-0233DRUG FOR FURTHER PROCESSING |
| - | nilotinib | capsule | 17088-0240DRUG FOR FURTHER PROCESSING |
| - | omalizumab | injection, solution | 17088-0268DRUG FOR FURTHER PROCESSING |
| - | omalizumab | injection, solution | 17088-0275DRUG FOR FURTHER PROCESSING |
| - | omalizumab | injection, solution | 17088-0282DRUG FOR FURTHER PROCESSING |
| - | omalizumab | injection, solution | 17088-0386DRUG FOR FURTHER PROCESSING |
| - | siponimod | tablet, film coated | 17088-0177DRUG FOR FURTHER PROCESSING |
| - | siponimod | tablet, film coated | 17088-0184DRUG FOR FURTHER PROCESSING |
| - | siponimod | tablet, film coated | 17088-0191DRUG FOR FURTHER PROCESSING |
| - | tislelizumab-jsgr | injection, solution, concentrate | 17088-0378DRUG FOR FURTHER PROCESSING |
| - | trametinib | tablet, film coated | 17088-0121DRUG FOR FURTHER PROCESSING |
| - | trametinib | tablet, film coated | 17088-0128DRUG FOR FURTHER PROCESSING |
Compare
Other companies listing everolimus
- Novartis Pharmaceuticals Corporation20 sites · 210 NDC
- Biocon Biologics Limited9 sites · 176 NDC
- Aurobindo Pharma Limited6 sites · 1,453 NDC
- Novugen Pharma Sdn. Bhd.1 site · 27 NDC
- Amneal Pharmaceuticals NY LLC0 sites · 337 NDC
- NorthStar RxLLC0 sites · 302 NDC
- i3 Pharmaceuticals, LLC0 sites · 19 NDC
Enquiry
Common questions
- Is Novartis Pharma Stein AG FDA approved?
- Novartis Pharma Stein AG holds no registered establishment of its own; 39 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Novartis Pharma Stein AG make?
- 39 products are listed under Novartis Pharma Stein AG in the openFDA NDC Directory, most often as tablet; tablet, film coated; injection, solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.